| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Phase I Pharmacokinetic Study of Trastuzumab Emtansine (T-DM1) in Patients with Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function
|
Li, Chunze
|
|
2016
|
56 |
9 |
p. 1069-1080
|
artikel
|
| 2 |
Caspofungin Population Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-Venous Haemofiltration or Haemodiafiltration
|
Roger, Claire
|
|
2016
|
56 |
9 |
p. 1057-1068
|
artikel
|
| 3 |
Clinical Pharmacokinetic Monitoring of Leflunomide in Renal Transplant Recipients with BK Virus Reactivation: A Review of the Literature
|
Ng, Joan C. Y.
|
|
|
56 |
9 |
p. 1015-1031
|
artikel
|
| 4 |
Clinical Pharmacokinetic Monitoring of Leflunomide in Renal Transplant Recipients with BK Virus Reactivation: A Review of the Literature
|
Ng, Joan C. Y.
|
|
2017
|
56 |
9 |
p. 1015-1031
|
artikel
|
| 5 |
Clinical Pharmacokinetics and Pharmacodynamics of Pazopanib: Towards Optimized Dosing
|
Verheijen, Remy B.
|
|
2017
|
56 |
9 |
p. 987-997
|
artikel
|
| 6 |
Clinical Pharmacokinetics of Vemurafenib
|
Zhang, Weijiang
|
|
2017
|
56 |
9 |
p. 1033-1043
|
artikel
|
| 7 |
Improved Pharmacokinetics with BAY 81-8973 Versus Antihemophilic Factor (Recombinant) Plasma/Albumin-Free Method: A Randomized Pharmacokinetic Study in Patients with Severe Hemophilia A
|
Shah, Anita
|
|
2016
|
56 |
9 |
p. 1045-1055
|
artikel
|
| 8 |
Pharmacokinetics of Rytary®, An Extended-Release Capsule Formulation of Carbidopa–Levodopa
|
Mittur, Aravind
|
|
2017
|
56 |
9 |
p. 999-1014
|
artikel
|
| 9 |
Population Pharmacokinetics and Immunogenicity of Adalimumab in Adult Patients with Moderate-to-Severe Hidradenitis Suppurativa
|
Nader, Ahmed
|
|
2017
|
56 |
9 |
p. 1091-1102
|
artikel
|
| 10 |
Remarkable Pharmacokinetics of Monoclonal Antibodies: A Quest for an Explanation
|
Reijers, Joannes A. A.
|
|
2016
|
56 |
9 |
p. 1081-1089
|
artikel
|
Tijdschrift beschrijving